Classification of Non-coding Variants with High Pathogenic Impact

Overview

Journal PLoS Genet

Specialty Genetics

Date 2022 Apr 29

PMID 35486646

Authors

Lambert Moyon

Camille Berthelot

Alexandra Louis

Nga Thi Thuy Nguyen

Hugues Roest Crollius

Affiliations

Soon will be listed here.

Abstract

Whole genome sequencing is increasingly used to diagnose medical conditions of genetic origin. While both coding and non-coding DNA variants contribute to a wide range of diseases, most patients who receive a WGS-based diagnosis today harbour a protein-coding mutation. Functional interpretation and prioritization of non-coding variants represents a persistent challenge, and disease-causing non-coding variants remain largely unidentified. Depending on the disease, WGS fails to identify a candidate variant in 20-80% of patients, severely limiting the usefulness of sequencing for personalised medicine. Here we present FINSURF, a machine-learning approach to predict the functional impact of non-coding variants in regulatory regions. FINSURF outperforms state-of-the-art methods, owing in particular to optimized control variants selection during training. In addition to ranking candidate variants, FINSURF breaks down the score for each variant into contributions from individual annotations, facilitating the evaluation of their functional relevance. We applied FINSURF to a diverse set of 30 diseases with described causative non-coding mutations, and correctly identified the disease-causative non-coding variant within the ten top hits in 22 cases. FINSURF is implemented as an online server to as well as custom browser tracks, and provides a quick and efficient solution to prioritize candidate non-coding variants in realistic clinical settings.

Citing Articles

Identification of a new spliceogenic variant causing severe primary coenzyme Q deficiency.

Alcazar-Fabra M, Ostergaard E, Fernandez-Ayala D, Desbats M, Morbidoni V, Tomas-Gallado L Mol Genet Metab Rep. 2025; 42:101176.

PMID: 39759098 PMC: 11699292. DOI: 10.1016/j.ymgmr.2024.101176.

Integrative computational analyses implicate regulatory genomic elements contributing to spina bifida.

Wolujewicz P, Aguiar-Pulido V, Thareja G, Suhre K, Elemento O, Finnell R Genet Med Open. 2024; 2:101894.

PMID: 39669613 PMC: 11613821. DOI: 10.1016/j.gimo.2024.101894.

Advancements in genetic research by the Hispanic Community Health Study/Study of Latinos: A 10-year retrospective review.

Rao H, Weiss M, Moon J, Perreira K, Daviglus M, Kaplan R HGG Adv. 2024; 6(1):100376.

PMID: 39473183 PMC: 11754138. DOI: 10.1016/j.xhgg.2024.100376.

3-hour genome sequencing and targeted analysis to rapidly assess genetic risk.

Zalusky M, Gustafson J, Bohaczuk S, Mallory B, Reed P, Wenger T Genet Med Open. 2024; 2.

PMID: 39421454 PMC: 11484281. DOI: 10.1016/j.gimo.2024.101833.

A Rare Noncoding Enhancer Variant in Contributes to the High Prevalence of Brugada Syndrome in Thailand.

Walsh R, Mauleekoonphairoj J, Mengarelli I, Bosada F, Verkerk A, van Duijvenboden K Circulation. 2024; 151(1):31-44.

PMID: 39391988 PMC: 11670919. DOI: 10.1161/CIRCULATIONAHA.124.069041.

References

Osterwalder M, Barozzi I, Tissieres V, Fukuda-Yuzawa Y, Mannion B, Afzal S . Enhancer redundancy provides phenotypic robustness in mammalian development. Nature. 2018; 554(7691):239-243. PMC: 5808607. DOI: 10.1038/nature25461. View

Clement Y, Torbey P, Gilardi-Hebenstreit P, Crollius H . Enhancer-gene maps in the human and zebrafish genomes using evolutionary linkage conservation. Nucleic Acids Res. 2020; 48(5):2357-2371. PMC: 7049698. DOI: 10.1093/nar/gkz1199. View

Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M . An atlas of active enhancers across human cell types and tissues. Nature. 2014; 507(7493):455-461. PMC: 5215096. DOI: 10.1038/nature12787. View

Siepel A, Bejerano G, Pedersen J, Hinrichs A, Hou M, Rosenbloom K . Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005; 15(8):1034-50. PMC: 1182216. DOI: 10.1101/gr.3715005. View

Caron B, Luo Y, Rausell A . NCBoost classifies pathogenic non-coding variants in Mendelian diseases through supervised learning on purifying selection signals in humans. Genome Biol. 2019; 20(1):32. PMC: 6371618. DOI: 10.1186/s13059-019-1634-2. View

Eberle M, Fritzilas E, Krusche P, Kallberg M, Moore B, Bekritsky M . A reference data set of 5.4 million phased human variants validated by genetic inheritance from sequencing a three-generation 17-member pedigree. Genome Res. 2016; 27(1):157-164. PMC: 5204340. DOI: 10.1101/gr.210500.116. View

Seaby E, Ennis S . Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies. Brief Funct Genomics. 2020; 19(4):243-258. DOI: 10.1093/bfgp/elaa009. View

Hait T, Amar D, Shamir R, Elkon R . FOCS: a novel method for analyzing enhancer and gene activity patterns infers an extensive enhancer-promoter map. Genome Biol. 2018; 19(1):56. PMC: 5930446. DOI: 10.1186/s13059-018-1432-2. View

Mohammadi P, Castel S, Cummings B, Einson J, Sousa C, Hoffman P . Genetic regulatory variation in populations informs transcriptome analysis in rare disease. Science. 2019; 366(6463):351-356. PMC: 6814274. DOI: 10.1126/science.aay0256. View

10.

Hinrichs A, Karolchik D, Baertsch R, Barber G, Bejerano G, Clawson H . The UCSC Genome Browser Database: update 2006. Nucleic Acids Res. 2005; 34(Database issue):D590-8. PMC: 1347506. DOI: 10.1093/nar/gkj144. View

11.

di Iulio J, Bartha I, Wong E, Yu H, Lavrenko V, Yang D . The human noncoding genome defined by genetic diversity. Nat Genet. 2018; 50(3):333-337. DOI: 10.1038/s41588-018-0062-7. View

12.

Kleinjan D, Heyningen V . Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet. 2004; 76(1):8-32. PMC: 1196435. DOI: 10.1086/426833. View

13.

Drubay D, Gautheret D, Michiels S . A benchmark study of scoring methods for non-coding mutations. Bioinformatics. 2018; 34(10):1635-1641. DOI: 10.1093/bioinformatics/bty008. View

14.

Gordon C, Attanasio C, Bhatia S, Benko S, Ansari M, Tan T . Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence. Hum Mutat. 2014; 35(8):1011-20. PMC: 4389788. DOI: 10.1002/humu.22606. View

15.

Lee C, Barber G, Casper J, Clawson H, Diekhans M, Gonzalez J . UCSC Genome Browser enters 20th year. Nucleic Acids Res. 2019; 48(D1):D756-D761. PMC: 7145642. DOI: 10.1093/nar/gkz1012. View

16.

Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T . GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017; 2017. PMC: 5467550. DOI: 10.1093/database/bax028. View

17.

Ghoussaini M, Mountjoy E, Carmona M, Peat G, Schmidt E, Hercules A . Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2020; 49(D1):D1311-D1320. PMC: 7778936. DOI: 10.1093/nar/gkaa840. View

18.

Smedley D, Schubach M, Jacobsen J, Kohler S, Zemojtel T, Spielmann M . A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease. Am J Hum Genet. 2016; 99(3):595-606. PMC: 5011059. DOI: 10.1016/j.ajhg.2016.07.005. View

19.

Gordon C, Lyonnet S . Enhancer mutations and phenotype modularity. Nat Genet. 2013; 46(1):3-4. DOI: 10.1038/ng.2861. View

20.

Liu X, Li C, Boerwinkle E . The performance of deleteriousness prediction scores for rare non-protein-changing single nucleotide variants in human genes. J Med Genet. 2016; 54(2):134-144. PMC: 5736365. DOI: 10.1136/jmedgenet-2016-104369. View